You are here

IID-1.1 Data Details

Expand All

IID-1.1 Maintain elimination of cases of vaccine-preventable congenital rubella syndrome (CRS) among children under 1 year of age (U.S.-acquired cases)

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

Data Source: 
National Notifiable Diseases Surveillance System (NNDSS); Centers for Disease Control and Prevention, Center for Surveillance, Epidemiology, and Laboratory Services (CDC/CSELS)
Changed Since the Healthy People 2020 Launch: 
No
Measure: 
number
Baseline (Year): 
2008
Target: 
0
Target-Setting Method: 
Total elimination
Target-Setting Method Justification: 
Endemic transmission of rubella was declared eliminated from the United States in 2004. In 2007 and 2008, a total of 9 and 13 U.S.-acquired rubella cases were reported in the United States, respectively. The Pan American Health Organization (PAHO) developed a comprehensive strategy in 2004 to eliminate rubella and CRS from the Americas by 2010. Countries have demonstrated progress toward the rubella and CRS elimination goal. Until rubella is eliminated from the Americas and other countries, rubella cases and possibly CRS cases will be likely in the United States. Subject matter experts have given the continued risk of rubella transmission in the United States consideration in setting the HP2020 target.
Numerator: 

Number of confirmed and probable U.S.-acquired cases of congenital rubella syndrome among children less than 1 year of age

Comparable Healthy People 2010 Objective: 
Retained from HP2010 objective
Data Collection Frequency: 
Annual
Methodology Notes: 

    A case definition for confirmed and probable US acquired cases of congenital rubella syndrome (CRS) is available from CDC. Imported cases of CRS are not included. CRS counts are based on year of birth, not year of report.

References

Additional resources about the objective

  1. Centers for Disease Control and Prevention (CDC). Case definitions for infectious conditions under public health surveillance.